Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4101 N Roxboro St
Durham, NC 27704Phone+1 919-684-8111
Education & Training
- University of MichiganFellowship, Nephrology, 2003 - 2005
- University of MichiganFellowship, Pediatric Nephrology, 2001 - 2003
- University of MichiganResidency, Internal Medicine/Pediatrics, 1997 - 2001
- University of California San Francisco School of MedicineClass of 1997
Certifications & Licensure
- NC State Medical License 2005 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant Start of enrollment: 2012 Jun 01
- Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) Start of enrollment: 2014 May 01
Publications & Presentations
PubMed
- 70 citationsPreoperative Serum Brain Natriuretic Peptide and Risk of Acute Kidney Injury After Cardiac SurgeryUptal D. Patel, Amit X. Garg, Harlan M. Krumholz, Michael G. Shlipak, Steven G. Coca
Circulation. 2012-03-20 - 149 citationsChronic kidney disease in low- and middle-income countries.John W. Stanifer, Anthony N. Muiru, Tazeen H. Jafar, Uptal D. Patel
Nephrology, Dialysis, Transplantation. 2016-06-01 - 102 citationsSafety and efficacy of drug-eluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database.Thomas T. Tsai, John C. Messenger, J. Matthew Brennan, Uptal D. Patel, David Dai
Journal of the American College of Cardiology. 2011-10-25
Press Mentions
- Kidney Disease Rates Have Stabilized in U.SNovember 7th, 2015
- New Strategies for Combatting Chronic Kidney Disease, Other Long-Term ConditionsJune 25th, 2015
- Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)November 3rd, 2023
- Join now to see all
Grant Support
- Barriers To Optimal Cardiovascular Medication Use In Diabetes And Renal DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: